全文获取类型
收费全文 | 8195篇 |
免费 | 900篇 |
国内免费 | 6篇 |
出版年
2022年 | 63篇 |
2021年 | 118篇 |
2020年 | 89篇 |
2019年 | 88篇 |
2018年 | 122篇 |
2017年 | 90篇 |
2016年 | 161篇 |
2015年 | 276篇 |
2014年 | 347篇 |
2013年 | 430篇 |
2012年 | 512篇 |
2011年 | 443篇 |
2010年 | 322篇 |
2009年 | 282篇 |
2008年 | 428篇 |
2007年 | 425篇 |
2006年 | 366篇 |
2005年 | 377篇 |
2004年 | 355篇 |
2003年 | 341篇 |
2002年 | 302篇 |
2001年 | 230篇 |
2000年 | 174篇 |
1999年 | 166篇 |
1998年 | 112篇 |
1997年 | 96篇 |
1996年 | 83篇 |
1995年 | 88篇 |
1994年 | 83篇 |
1993年 | 73篇 |
1992年 | 155篇 |
1991年 | 144篇 |
1990年 | 135篇 |
1989年 | 127篇 |
1988年 | 106篇 |
1987年 | 118篇 |
1986年 | 82篇 |
1985年 | 76篇 |
1984年 | 91篇 |
1983年 | 77篇 |
1982年 | 72篇 |
1981年 | 49篇 |
1980年 | 51篇 |
1979年 | 74篇 |
1978年 | 49篇 |
1977年 | 54篇 |
1976年 | 49篇 |
1975年 | 68篇 |
1973年 | 52篇 |
1972年 | 52篇 |
排序方式: 共有9101条查询结果,搜索用时 15 毫秒
21.
22.
23.
24.
John W. Wright Anita J. Bechtholt Shelley L. Chambers Joseph W. Harding 《Peptides》1996,17(8):1365-1371
The present investigation determined that native angiotensins II and III (ANG II and III) were equipotent as pressor agents when ICV infused in alert rats, whereas native angiotensin IV (ANG IV) was less potent. An analogue of each of these angiotensins was prepared with a hydroxyethylamine (HEA) amide bond replacement at the N-terminus, yielding additional resistance to degradation. These three angiotensin analogues, HEA-ANG II, HEA-ANG III, and HEA-ANG IV, were equivalent with respect to maximum elevation in pressor responses when ICV infused; and each evidenced significantly extended durations of effect compared with their respective native angiotensin. Comparing analogues, HEA-ANG II had a significantly longer effect compared with HEA-ANG III, and HEA-ANG IV, whereas the latter were equivalent. Pretreatment with the AT1 receptor subtype antagonist, Losartan (DuP753), blocked subsequent pressor responses to each of these analogues, suggesting that these responses were mediated by the AT1 receptor subtype. Pretreatment with the specific AT4 receptor subtype antagonist, Divalinal (HED 1291), failed to influence pressor responses induced by the subsequent infusion of these analogues. These results suggest an important role for Ang III, and perhaps ANG IV, in brain angiotensin pressor responses mediated by the AT1 receptor subtype. 相似文献
25.
Y. S. Cheng J. L. Halsey K. A. Fode C. C. Remsen M. L. P. Collins 《Applied microbiology》1999,65(2):648-651
26.
27.
We have addressed the role of the F-box helicase 1 (Fbh1) protein during genome maintenance in mammalian cells. For this, we generated two mouse embryonic stem cell lines deficient for Fbh1: one with a homozygous deletion of the N-terminal F-box domain (Fbh1f/f), and the other with a homozygous disruption (Fbh1?/?). Consistent with previous reports of Fbh1-deficiency in vertebrate cells, we found that Fbh1?/? cells show a moderate increase in Rad51 localization to DNA damage, but no clear defect in chromosome break repair. In contrast, we found that Fbh1f/f cells show a decrease in Rad51 localization to DNA damage and increased cytoplasmic localization of Rad51. However, these Fbh1f/f cells show no clear defects in chromosome break repair. Since some Rad51 partners and F-box-associated proteins (Skp1-Cul1) have been implicated in progression through mitosis, we considered whether Fbh1 might play a role in this process. To test this hypothesis, we disrupted mitosis using catalytic topoisomerase II inhibitors (bisdioxopiperazines), which inhibit chromosome decatenation. We found that both Fbh1f/f and Fbh1?/? cells show hypersensitivity to topoisomerase II catalytic inhibitors, even though the degree of decatenation stress was not affected. Furthermore, following topoisomerase II catalytic inhibition, both Fbh1-deficient cell lines show substantial defects in anaphase separation of chromosomes. These results indicate that Fbh1 is important for restoration of normal mitotic progression following decatenation stress. 相似文献
28.
29.
30.
R. Myles Riner Kathryn Maino Collins Garrett E. Foulke George V. Moorhead Phillip Terry 《The Western journal of medicine》1987,147(5):602-608
In a pilot project sponsored by the California State Emergency Medical Services Authority, validated, verifiable criteria were developed for the vertical categorization of hospital emergency services in 11 different groupings of medical and surgical emergencies. We describe the development of an assessment process and categorization criteria to identify the most appropriate receiving facility for interfacility transfer and, in selected instances, field triage of patients with different levels of severity of illness or injury. We propose that this facility assessment project be used in the critical care planning process for the eventual vertical categorization of hospital emergency services in California and as a template for similar projects in other states. 相似文献